List of Swedish Orphan Biovitrum patents

Patents where

Current Assignee

Name

Swedish Orphan Biovitrum

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7071180 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases	Patent 7071180 was granted and assigned to Swedish Orphan Biovitrum on July, 2006 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7071180	July 4, 2006
‌ US Patent 7030135 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1	Patent 7030135 was granted and assigned to Swedish Orphan Biovitrum on April, 2006 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7030135	April 18, 2006
‌ US Patent 9808502 Polypeptides binding to human complement C5	Patent 9808502 was granted and assigned to Swedish Orphan Biovitrum on November, 2017 by the United States Patent and Trademark Office.	Swedish Orphan Biovitrum	Swedish Orphan Biovitrum	United States Patent and Trademark Office	9808502	November 7, 2017
‌ US Patent 10206975 Polypeptides binding to human complement C5	Patent 10206975 was granted and assigned to Swedish Orphan Biovitrum on February, 2019 by the United States Patent and Trademark Office.	Swedish Orphan Biovitrum	Swedish Orphan Biovitrum	United States Patent and Trademark Office	10206975	February 19, 2019
‌ US Patent 9982243 Modified sulfamidase and production thereof	Patent 9982243 was granted and assigned to Swedish Orphan Biovitrum on May, 2018 by the United States Patent and Trademark Office.	Swedish Orphan Biovitrum	Swedish Orphan Biovitrum	United States Patent and Trademark Office	9982243	May 29, 2018
‌ US Patent 7144883 Bicyclic sulfonamide compounds	Patent 7144883 was granted and assigned to Swedish Orphan Biovitrum on December, 2006 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7144883	December 5, 2006
‌ US Patent 7718650 Aryl sulfonamide compounds for treating obesity	Patent 7718650 was granted and assigned to Swedish Orphan Biovitrum on May, 2010 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7718650	May 18, 2010
‌ US Patent 7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system	Patent 7566715 was granted and assigned to Swedish Orphan Biovitrum on July, 2009 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7566715	July 28, 2009
‌ US Patent 11324807 Compositions comprising anakinra	Patent 11324807 was granted and assigned to Swedish Orphan Biovitrum on May, 2022 by the United States Patent and Trademark Office.	Swedish Orphan Biovitrum	Swedish Orphan Biovitrum	United States Patent and Trademark Office	11324807	May 10, 2022
‌ US Patent 7618961 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1	Patent 7618961 was granted and assigned to Swedish Orphan Biovitrum on November, 2009 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7618961	November 17, 2009
‌ US Patent 6969710 Compounds	Patent 6969710 was granted and assigned to Swedish Orphan Biovitrum on November, 2005 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	6969710	November 29, 2005
‌ US Patent 6891035 Process for bulk autoclaving	Patent 6891035 was granted and assigned to Swedish Orphan Biovitrum on May, 2005 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	6891035	May 10, 2005
‌ US Patent 7285392 Methods for identifying active compounds	Patent 7285392 was granted and assigned to Swedish Orphan Biovitrum on October, 2007 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7285392	October 23, 2007
‌ US Patent 7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1	Patent 7132436 was granted and assigned to Swedish Orphan Biovitrum on November, 2006 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7132436	November 7, 2006
‌ US Patent 7045294 Promoter sequences	Patent 7045294 was granted and assigned to Swedish Orphan Biovitrum on May, 2006 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7045294	May 16, 2006
‌ US Patent 7572787 Substituted naphthalene sulfonamides	Patent 7572787 was granted and assigned to Swedish Orphan Biovitrum on August, 2009 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7572787	August 11, 2009
‌ US Patent 7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1	Patent 7125900 was granted and assigned to Swedish Orphan Biovitrum on October, 2006 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7125900	October 24, 2006
‌ US Patent 7173035 Arylsulfonamide compounds	Patent 7173035 was granted and assigned to Swedish Orphan Biovitrum on February, 2007 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7173035	February 6, 2007
‌ US Patent 7319097 Compounds	Patent 7319097 was granted and assigned to Swedish Orphan Biovitrum on January, 2008 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7319097	January 15, 2008
‌ US Patent 10179162 Citrate free pharmaceutical compositions comprising anakinra	Patent 10179162 was granted and assigned to Swedish Orphan Biovitrum on January, 2019 by the United States Patent and Trademark Office.	Swedish Orphan Biovitrum	Swedish Orphan Biovitrum	United States Patent and Trademark Office	10179162	January 15, 2019
‌ US Patent 7129354 Process for the preparation of stable acid addition salt of 2,3-disubstituted pyrazine compounds	Patent 7129354 was granted and assigned to Swedish Orphan Biovitrum on October, 2006 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7129354	October 31, 2006
‌ US Patent 9994626 Stable polypeptides binding to human complement C5	Patent 9994626 was granted and assigned to Swedish Orphan Biovitrum on June, 2018 by the United States Patent and Trademark Office.	Swedish Orphan Biovitrum	Swedish Orphan Biovitrum	United States Patent and Trademark Office	9994626	June 12, 2018
‌ US Patent 7709526 Use of cyclolignans and new cyclolignans	Patent 7709526 was granted and assigned to Swedish Orphan Biovitrum on May, 2010 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7709526	May 4, 2010
‌ US Patent 7094792 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1	Patent 7094792 was granted and assigned to Swedish Orphan Biovitrum on August, 2006 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7094792	August 22, 2006
‌ US Patent 7226925 Compounds, their use and preparation	Patent 7226925 was granted and assigned to Swedish Orphan Biovitrum on June, 2007 by the United States Patent and Trademark Office.		Swedish Orphan Biovitrum	United States Patent and Trademark Office	7226925	June 5, 2007

Results per page:

41 results

0 selected

41 results

0 selected